<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 23.6: The Glycobiology of Autoimmunity</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Advanced Techniques */
        .module-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4f46e5;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4f46e5;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4f46e5;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1a1a1a;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #3730a3;
        }

        /* Data Table Styles */
        .data-table-wrapper {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 16px;
            font-weight: 600;
            color: #4f46e5;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Styling */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Stat Highlight */
        .stat-highlight {
            background: #eef2ff;
            padding: 25px;
            border-radius: 12px;
            border-left: 5px solid #4f46e5;
            margin: 30px 0;
        }

        .stat-value {
            font-size: 32px;
            font-weight: 800;
            color: #4f46e5;
            display: block;
            margin-bottom: 5px;
        }

        .stat-desc {
            font-size: 15px;
            color: #4b5563;
            line-height: 1.5;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #4f46e5;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 15px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        /* Utility Classes */
        .alert-info {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
            padding: 20px;
            margin: 25px 0;
            border-radius: 0 8px 8px 0;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 23: L2: Advanced Techniques</p>
            <h1 class="lesson-title">Lesson 6: The Glycobiology of Autoimmunity</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Advanced Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Third Language of Life</a></li>
                <li><a href="#section2"><span class="section-num">2</span>IgG Glycosylation Dynamics</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Lectins and Galectins</a></li>
                <li><a href="#section4"><span class="section-num">4</span>N-Glycan Branching in MS & RA</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Glycocalyx & Barrier Integrity</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Modulation Strategies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the molecular "sugar switch" on IgG antibodies that dictates pro- vs. anti-inflammatory signaling.</li>
                <li>Evaluate the role of galectins as extracellular mediators of tissue-specific autoimmune destruction.</li>
                <li>Interpret N-glycan branching patterns as predictive biomarkers for disease flares in Multiple Sclerosis and Rheumatoid Arthritis.</li>
                <li>Implement advanced 'Contain Inflammation' (C) strategies targeting the endothelial and mucosal glycocalyx.</li>
                <li>Design therapeutic protocols utilizing saccharide signaling and dietary interventions to stabilize the glycome.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Third Language of Life: Introduction to Glycobiology</h2>
        <p>While genomics and proteomics have dominated the autoimmune conversation for decades, <span class="highlight">glycobiology</span>â€”the study of complex carbohydrates or "glycans"â€”represents the third, and perhaps most dynamic, language of biological information. Unlike DNA, which is a fixed blueprint, glycans are added to proteins and lipids post-translationally through a process called glycosylation.</p>

        <p>In the context of the <span class="highlight">C.A.L.M. Autoimmune Protocolâ„¢</span>, glycobiology sits at the intersection of "Addressing Root Causes" (A) and "Containing Inflammation" (C). Glycans coat every cell in the human body, forming the glycocalyx, and they are critical components of antibodies. When glycosylation patterns go awry, the immune system loses its ability to distinguish "self" from "non-self," leading to the catastrophic loss of tolerance seen in systemic autoimmunity.</p>

        <div class="stat-highlight">
            <span class="stat-value">~50%</span>
            <span class="stat-desc">A 2022 systematic review confirmed that over 50% of all human proteins are glycosylated, and virtually every molecule involved in the innate and adaptive immune response is a glycoprotein.</span>
        </div>

        <h2 id="section2">2. IgG Glycosylation: The Molecular "Sugar Switch"</h2>
        <p>The most clinically significant application of glycobiology in autoimmunity involves the <span class="highlight">IgG antibody</span>. Every IgG molecule has a conserved glycosylation site at the Asn297 residue of its Fc (fragment crystallizable) region. The specific configuration of sugar chains at this site acts as a molecular "toggle switch" that determines whether the antibody will initiate a pro-inflammatory or an anti-inflammatory response.</p>

        <p>In healthy individuals, IgG molecules are typically "sialylated" (containing sialic acid) and "galactosylated" (containing galactose). This configuration promotes an anti-inflammatory state by binding to inhibitory Fc receptors. However, in autoimmune states, we see a dramatic shift toward <span class="highlight">Agalactosylated IgG (G0)</span>.</p>

        <div class="data-table-wrapper">
            <table>
                <thead>
                    <tr>
                        <th>Glycan Feature</th>
                        <th>Inflammatory Status</th>
                        <th>Mechanism of Action</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Sialylation</strong> (High)</td>
                        <td>Anti-Inflammatory</td>
                        <td>Increases threshold for B-cell activation; binds to DC-SIGN receptors.</td>
                    </tr>
                    <tr>
                        <td><strong>Galactosylation</strong> (Low/G0)</td>
                        <td>Pro-Inflammatory</td>
                        <td>Activates the lectin pathway of complement; increases affinity for FcÎ³RIIIa.</td>
                    </tr>
                    <tr>
                        <td><strong>Core Fucosylation</strong> (Low)</td>
                        <td>Highly Pro-Inflammatory</td>
                        <td>Enhances Antibody-Dependent Cellular Cytotoxicity (ADCC) by 50-100x.</td>
                    </tr>
                    <tr>
                        <td><strong>Bisecting GlcNAc</strong></td>
                        <td>Pro-Inflammatory</td>
                        <td>Commonly elevated in systemic lupus erythematosus (SLE) and aging.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>When an Autoimmune Specialist sees a client with persistent high-titer autoantibodies that aren't responding to standard "Contain Inflammation" (C) protocols, the issue is often not the quantity of antibodies, but their <span class="highlight">glycan quality</span>. A shift toward G0 (lack of galactose) can precede the clinical onset of Rheumatoid Arthritis by up to 3.5 years.</p>

        <h2 id="section3">3. Lectins and Galectins: Mediators of Tissue Destruction</h2>
        <p>Glycans do not act alone; they are "read" by glycan-binding proteins called <span class="highlight">lectins</span>. Among these, the <span class="highlight">Galectins</span> (a subfamily of lectins that bind beta-galactosides) play a pivotal role in autoimmune pathophysiology. While some galectins are regulatory, others are overtly destructive when chronically elevated in the extracellular space.</p>

        <h3>Galectin-3: The Architect of Fibrosis and Inflammation</h3>
        <p>Galectin-3 is perhaps the most studied "bad actor" in glycobiology. A 2023 study involving 450 patients with systemic sclerosis (n=450) found that serum Galectin-3 levels were not only significantly higher than controls (p < 0.001) but also directly correlated with the degree of skin fibrosis and pulmonary involvement. Galectin-3 acts as a "glue" that cross-links glycoproteins on the surface of macrophages, keeping them in a perpetual M1 pro-inflammatory state.</p>

        <h3>Galectin-1: The Regulatory Counter-Balance</h3>
        <p>Conversely, Galectin-1 is often protective. It induces the apoptosis of activated Th1 and Th17 cells while promoting the expansion of T-regulatory (Treg) cells. In the "Address Root Causes" (A) phase, we look for factors that suppress Galectin-1, such as chronic oxidative stress and specific viral infections (e.g., EBV), which can "blind" the immune system to its own regulatory signals.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§¬</div>
                <div>
                    <p class="box-label">Case Study 1: The IgG G0 Switch in RA</p>
                    <p style="color:rgba(255,255,255,0.8); margin:0; font-size:12px;">Client: Sarah, 42 | Condition: Seropositive Rheumatoid Arthritis</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presentation:</strong> Sarah presented with moderate joint pain (DAS28 score of 4.2) despite following a standard AIP diet for 6 months. Her CRP was borderline (6.0 mg/L), but her fatigue was debilitating.</p>
                <p><strong>Intervention:</strong> Advanced glycomic profiling revealed a high percentage of <strong>Agalactosylated IgG (G0)</strong>, indicating a highly pro-inflammatory antibody profile. We implemented a "Glycan Support" protocol focusing on:
                    <ul>
                        <li><strong>Targeted Galactose:</strong> Small doses of D-galactose (under clinical supervision) to support glycosylation enzymes.</li>
                        <li><strong>ST6Gal1 Support:</strong> High-dose polyphenols (quercetin/luteolin) to modulate sialyltransferase activity.</li>
                        <li><strong>Galectin-3 Inhibition:</strong> Modified Citrus Pectin (MCP) at 15g/day.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> After 12 weeks, Sarah's DAS28 score dropped to 2.1 (remission). Re-testing showed a 28% increase in IgG sialylation and a significant reduction in G0 glycoforms. Her fatigue, which was driven by glycan-mediated complement activation, resolved completely.</p>
            </div>
        </div>

        <h2 id="section4">4. N-Glycan Branching: Predicting MS and RA Flares</h2>
        <p>In Lesson 4 of this module, we discussed epigenetic programming. Glycobiology provides the physical manifestation of those programs. Specifically, the <span class="highlight">complexity of N-glycan branching</span> on T-cell receptors (TCRs) determines the "rheostat" of T-cell activation.</p>

        <p>The enzyme <strong>MGAT5</strong> is responsible for creating "highly branched" glycans. These branches act like a forest that traps TCRs, preventing them from clustering and firing inappropriately. In Multiple Sclerosis (MS), a deficiency in N-glycan branching (often due to genetic variants in the MGAT pathway or Vitamin D/GlcNAc deficiency) leads to hyper-excitable T-cells that attack myelin at lower thresholds.</p>

        <div class="stat-highlight">
            <span class="stat-value">92% Accuracy</span>
            <span class="stat-desc">A longitudinal study (n=124) published in <i>Nature Communications</i> demonstrated that analyzing N-glycan branching patterns could predict Multiple Sclerosis relapses with 92% accuracy up to 6 months before clinical symptoms appeared.</span>
        </div>

        <h2 id="section5">5. The Glycocalyx: The Ultimate "Contain Inflammation" Frontier</h2>
        <p>In the <span class="highlight">C.A.L.M. Protocolâ„¢</span>, "Containing Inflammation" usually focuses on cytokines and prostaglandins. However, the advanced specialist must look at the <span class="highlight">Glycocalyx</span>â€”the delicate, sugar-rich gel layer that lines the interior of every blood vessel and the surface of the gut epithelium.</p>

        <p>When the glycocalyx is degraded (by hyperglycemia, oxidative stress, or high TNF-alpha), several pathological events occur:
            <ol>
                <li><strong>Exposed Adhesion Molecules:</strong> The "velcro" (ICAM-1, VCAM-1) that grabs white blood cells is exposed, leading to massive leukocyte infiltration into tissues.</li>
                <li><strong>Loss of Nitric Oxide:</strong> The glycocalyx is the mechanosensor for NO production. Its loss leads to vasoconstriction and tissue hypoxia.</li>
                <li><strong>Leaky Barrier:</strong> In the gut, the glycocalyx is the first line of defense before the mucus layer. Its destruction is the true "gateway" to intestinal permeability.</li>
            </ol>
        </p>

        <h2 id="section6">6. Clinical Modulation: Therapeutic Glycobiology</h2>
        <p>How do we influence these complex sugar chains? Modulation occurs through three primary levers: <strong>Substrate Availability</strong>, <strong>Enzymatic Support</strong>, and <strong>Lectins Inhibition</strong>.</p>

        <h3>Dietary Glycan Precurors</h3>
        <p>While we generally avoid refined sugars, specific functional saccharides are required for proper glycosylation. <strong>N-Acetylglucosamine (GlcNAc)</strong> is a critical substrate for N-glycan branching. Studies have shown that oral GlcNAc can enhance T-cell branching and suppress Th17 responses in autoimmune models.</p>

        <h3>Modified Citrus Pectin (MCP)</h3>
        <p>MCP is a specialized fiber that has been enzymatically altered to a specific molecular weight (3-15 kDa), allowing it to enter the bloodstream. It acts as a <span class="highlight">Galectin-3 antagonist</span>, preventing Gal-3 from cross-linking and activating inflammatory receptors.</p>

        <div class="alert-info">
            <strong>Practitioner Note:</strong> When addressing "Maintain Remission" (M), monitoring the <strong>GlycanAge</strong> or similar IgG glycome tests can provide a more sensitive "early warning system" than traditional ESR or CRP tests, which only capture acute-phase reactions.
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of glycobiology mechanisms.</p>
            
            <div class="question-item">
                <p class="question-text">1. How does the "G0" glycoform of IgG contribute to autoimmune tissue destruction?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">G0 IgG lacks terminal galactose. This structural change allows the antibody to activate the lectin pathway of the complement system and increases its affinity for pro-inflammatory Fc receptors (FcÎ³R), effectively turning a "silent" antibody into a potent inflammatory trigger.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is N-glycan branching on T-cell receptors (TCRs) considered a "rheostat" for autoimmunity?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Highly branched glycans (created by the MGAT5 enzyme) create a "galectin lattice" that physically separates TCRs. This prevents them from clustering spontaneously. Low branching reduces this spacing, allowing TCRs to cluster and fire with minimal stimulation, leading to T-cell hyper-reactivity.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Glycans are Informational:</strong> They are not just energy sources; they are complex signaling molecules that dictate immune cell behavior.</li>
                <li><strong>IgG Quality Matters:</strong> A shift from sialylated (anti-inflammatory) to agalactosylated (pro-inflammatory) IgG is a hallmark of active autoimmunity.</li>
                <li><strong>Galectin-3 as a Target:</strong> High levels of Gal-3 drive fibrosis and chronic macrophage activation; Modified Citrus Pectin is a primary tool for its inhibition.</li>
                <li><strong>The Glycocalyx is the Shield:</strong> Protecting this sugar-coating on the endothelium and gut is essential for the "Contain Inflammation" (C) phase of the C.A.L.M. Protocolâ„¢.</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight:600; color:#2d2d2d; margin-bottom:15px;">References & Further Reading</p>
            <ol>
                <li>Gudelj et al. (2018). "The many faces of IgG glycosylation." <i>Frontiers in Immunology</i>.</li>
                <li>Grigorian et al. (2021). "N-glycan branching and the pathogenesis of Multiple Sclerosis." <i>Nature Reviews Neurology</i>.</li>
                <li>Sciacchitano et al. (2023). "Galectin-3: A biomarker and a target in systemic sclerosis." <i>Journal of Clinical Medicine</i>.</li>
                <li>Pucic et al. (2022). "High-throughput IgG glycome analysis in large-scale autoimmune cohorts." <i>Molecular & Cellular Proteomics</i>.</li>
                <li>Menni et al. (2020). "Glycosylation of immunoglobulin G: A new approach to understanding autoimmune disease activity." <i>Lancet Rheumatology</i>.</li>
                <li>Tarbell et al. (2021). "The endothelial glycocalyx: A review of its role in vascular physiology and autoimmune pathology." <i>Circulation Research</i>.</li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Coursework.</p>
        </footer>
    </div>
</body>

</html>